GeneDx Holdings Corp.

WGS · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Operating Activities
Net Income-$52-$176-$549-$245
Dep. & Amort.$22$36$59$22
Deferred Tax-$0-$1-$49$0
Stock-Based Comp.$9-$0$42$219
Change in WC-$25-$38$36$8
Other Non-Cash$18-$1$142-$194
Operating Cash Flow-$28-$180-$319-$190
Investing Activities
PP&E Inv.-$5-$6-$14-$9
Net Acquisitions$0-$8-$127$0
Inv. Purchases-$66-$48$0$0
Inv. Sales/Matur.$42$18$0$0
Other Inv. Act.$0$0$0-$11
Investing Cash Flow-$30-$44-$141-$21
Financing Activities
Debt Repay.-$3$43-$3-$13
Stock Issued$46$143$198$443
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.$1$0$3$65
Financing Cash Flow$44$186$197$494
Forex Effect$0-$0$0$0
Net Chg. in Cash-$14-$38-$263$283
Supplemental Information
Beg. Cash$101$137$401$119
End Cash$86$100$138$401
Free Cash Flow-$34-$186-$333-$211
GeneDx Holdings Corp. (WGS) Financial Statements & Key Stats | AlphaPilot